Learning Objectives:
- Understand the mechanisms by which advanced prostate and other immune-refractory cancers evade anti-tumor immunity
- Elucidate therapeutic strategies to enhance innate immunity within the tumor microenvironment, thereby overcoming resistance to immunotherapy.
- Discuss the development of immuno-oncology combination clinical trials in molecularly-defined subsets of advanced prostate and endometrial cancers.
Session date:
08/26/2019 - 12:00pm to 1:00pm CDT
Location:
UCMC
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Akash Patnaik, MD, PhD, MMSc